Although this was similar to the frequency of 23–33% identified by many studies, [3]–[4], [9], [15]–[16], [22] elevated ANA has also been detected in higher (47–81%) [12], [18], [22] and lower (3%–19%) frequency in MS patients [5], [19]–[21], [23] in additional literature. Here, BTG3 is linked to myeloid sarcoma.